NanoViricides Inc

Research NanoViricides Inc (NNVC) on Bullrun: market cap USD 31.21M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNNVC
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 31.21M
• Financial periodFY2025
• Net income-USD 9.47M
• Free cash flow-USD 8.54M

Valuation Snapshot

latest market cap is USD 31.21M.

About NanoViricides Inc

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability;

Frequently asked questions

What is NanoViricides Inc's market cap?

NanoViricides Inc's market capitalization is USD 31.21M.

What does NanoViricides Inc do?

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections.